An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Focal Seizures in Tuberous Sclerosis Complex.

Conditions:   Tuberous Sclerosis Complex;   Seizures, FocalIntervention:   Drug: GWP42003-PSponsor:   GW Research LtdNot yet recruiting - verified September 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials